자산 1
CLEO ONE
ENG KOR

Notice

  • CLEO™ Q16 Real-Time PCR system receives ANVISA registration in Brazil

    September 18 2025

  • Wizbiosolutions is pleased to announce that its CLEO™ Q16 real-time PCR system has been successfully registered as a Class II in vitro diagnostic (IVD) device with the Brazilian Health Regulatory Agency (ANVISA).
    The CLEO™ Q16 features four fluorescence channels and rapid PCR performance, enabling the amplification of up to 16 samples simultaneously. Its compact design makes it an excellent solution for small diagnostic laboratories and point-of-care testing.